United States · Investor

Illumina Ventures

Last cheque observed Sep 2026; 48 cheques on record.

Deploying nowVC firm

Pre-seedSeedSeries ASpectrometryCelle TherapyMedical Device

Deploying now
79%of best year11cheques in 12 months, 48 on record
Since the last cheque60days00hrs00min00sec
Median round$17MCheque size, as they say$500K – $10MRounds led1 of 48Sole investor4 roundsMostly inUnited States, 78%
Pitch Illumina Ventures

Illumina Ventures highlights

  1. 01

    11 cheques in the last 12 months

  2. 02

    Mostly Series A and Venture: 61% of its rounds

  3. 03

    Sole investor in 4 rounds, median $10M

What they do

Illumina Ventures is the leader in genomics and precision health investing.From their own website
Type
VC firm (from a list, unverified)
Cheque size
$500K – $10M as they say
Stages
Pre-seedSeedSeries A
Sectors
SpectrometryCelle TherapyMedical Device
Based in
Foster City, United States
Cold pitches
Not accepted

The record

Every round we can evidence, newest first48 appearances

  1. 2026

    9 rounds

  2. Sept
    CubaseBioGrant · SE$4.6MWith 3 others
  3. Sept
    RobigoSeries A · US · AgFunderNewsUndisclosedWith 5 others
  4. Aug
    Integrated BiosciencesVenture · US$68MWith 2 others
  5. Jul
    Syntax BioSeries A · US · Firms' own news pages$14MWith 3 others
  6. Jun
    SonoTheraSeries B · US · Ventureburn$125MWith 10 others
  7. Apr
    LightcastVenture · GB · Ventureburn$27MWith 5 others
  8. Feb
    CubaseBioSeed · SE$4.6MWith 3 others
  9. Jan
    Alamar BiosciencesUS$50MWith 4 others
  10. Jan
    Precede BiosciencesSeries B · US$64MWith 2 others
  11. 2025

    12 rounds

  12. Dec
    SyntaxBioGrant · US$856KWith 2 others
  13. Nov
    Hepta BioSeed · US$6.7MWith 4 others
  14. Oct
    Predicta BiosciencesSeries A · US$23MWith 1 other
  15. Aug
    Pattern BioscienceVenture · US$44MSole investor
  16. Jul
    NuCicerSeries A · US$12MWith 4 others
  17. Jul
    Broken String BiosciencesVenture · GBUndisclosedWith 2 others
  18. Jun
    TagomicsGrant · GB$1.2MWith 3 others
  19. Jun
    Arima GenomicsSeries C · US$22MWith 2 others
  20. Jun
    Infinity BioSeries A · US$8.0MSole investor
  21. Apr
    Attovia TherapeuticsSeries C · US$90MWith 3 others
  22. Apr
    Biosynch.aiSeed · US$4.2MWith 3 others
  23. Jan
    LetsGetCheckedSeries F · US$165MWith 3 others
  24. 2024

    5 rounds

  25. Oct
    Integrated BiosciencesSeed · US$17MWith 2 others
  26. Sept
    Genome MedicalSeries D · US$75MWith 6 others
  27. Aug
    Human LongevitySeries B · US$40MWith 1 other
  28. Mar
    FLUENTSeed · CA$7.5MWith 3 others
  29. Feb
    Stilla TechnologiesSeries C · FR$27MWith 4 others
  30. 2023

    4 rounds

  31. Oct
    Actym Therapeutics, Inc.Series A · US$26MWith 2 others
  32. Sept
    Broken String BiosciencesSeries A · GB$15MWith 2 others
  33. May
    KallyopeGrant · US$8.2MWith 5 others
  34. May
    Pluton BiosciencesSeries A · US$17MWith 3 others
  35. 2022

    5 rounds

  36. Dec
    Protillion BiosciencesSeries A · US$18MWith 1 other
  37. Nov
    Sherlock BiosciencesVenture · USUndisclosedWith 2 others
  38. Mar
    SQZ BiotechGrant · US$2.0MWith 4 others
  39. Feb
    Twist BioscienceUS$250MWith 5 others
  40. Feb
    Walking Fish TherapeuticsSeries A · US$23MWith 1 other
  41. 2021

    2 rounds

  42. May
    LunaPBCVenture$3.8MWith 2 others
  43. Mar
    Encoded TherapeuticsVenture · USUndisclosedWith 4 others
  44. 2020

    2 rounds

  45. Sept
    SerImmuneVenture$12MSole investor
  46. May
    SQZ BiotechnologiesSeries D · US · Firms' own news pages$65MWith 6 others
  47. 2019

    5 rounds

  48. Nov
    Desktop GeneticsCrowdfunding$1.9MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

DDDonal Denis DelaneyChief Compliance Officer & Chief Financial OfficeriForm ADV
NNNicholas NaclerioManaging MemberiForm ADV

We also hold 16 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$643Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
IIF Management Company, LLC
SEC number
CRD 283782

What they claim to have backed

From their own portfolio page (on their website)

7 of 39 we have independently watched raise

CompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompany

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Illumina Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Illumina Ventures put money into.

Quick answers about Illumina Ventures

What does Illumina Ventures invest in?

Illumina Ventures invests most often at Series A and Venture (61% of the rounds on record), in sectors such as Spectrometry, Celle Therapy and Medical Device.

How active is Illumina Ventures?

48 investments on record, 11 of them in the last 12 months, and it led 1. The most recent was in Sept 2026.

What has Illumina Ventures invested in recently?

Its most recent investments on record: CubaseBio (Grant, Sept 2026), Robigo (Series A, Sept 2026) and Integrated Biosciences (Venture, Aug 2026).

How big are Illumina Ventures's cheques?

The median round it joins is $17M. It says it writes cheques of $500K to $10M.

Does Illumina Ventures lead rounds?

Sometimes: it led 1 of its 48 investments on record (2%).

Where does Illumina Ventures invest?

Most of the companies it backs are in the United States (78%), the United Kingdom (11%) and Sweden (5%).

Is Illumina Ventures investing now?

Yes: it is actively investing, with 11 investments in the last 12 months.

Who does Illumina Ventures invest alongside?

Most often ARCH Venture Partners (7 rounds together), Alexandria Real Estate Equities (3 rounds together) and Alumni Ventures (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it